The Enterprise Value as of December 2024 (TTM) for Myomo, Inc. (MYO) is 205.39M

According to Myomo, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 205.39M. This represents a change of 53.84% compared to the average of 133.50M of the last 4 quarters.

Myomo, Inc. (MYO) Historical Enterprise Value (quarterly & annually)

How has MYO Enterprise Value performed in the past?

The mean historical Enterprise Value of Myomo, Inc. over the last ten years is 163.58M. The current 205.39M Enterprise Value has changed 12.46% with respect to the historical average. Over the past ten years (40 quarters), MYO's Enterprise Value was at its highest in in the June 2016 quarter at 1.43B. The Enterprise Value was at its lowest in in the March 2020 quarter at -5949101.44.

Myomo, Inc. (MYO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Myomo, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Myomo, Inc. (MYO) Average Enterprise Value

How has MYO Enterprise Value performed in the past?

The current Enterprise Value of Myomo, Inc. (MYO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Myomo, Inc. (MYO) Enterprise Value vs. Peers

How is MYO’s Enterprise Value compared to its peers?

Myomo, Inc.’s Enterprise Value is greater than Sintx Technologies, Inc. (4.51M), greater than ReShape Lifesciences Inc. (2.69M), greater than Bone Biologics Corporation (-1226069.00), greater than Ra Medical Systems, Inc. (-1531031.00), greater than Tivic Health Systems, Inc. (269.33K), greater than Bluejay Diagnostics, Inc. (-3512758.00), greater than Vivos Therapeutics, Inc. (17.82M), greater than Rapid Micro Biosystems, Inc. (25.64M), greater than Talis Biomedical Corporation (-37942687.00), greater than Nuwellis, Inc. (3.81M), greater than Heart Test Laboratories, Inc. (-1145233588.00), greater than Nexalin Technology, Inc. (37.86M), less than INVO Bioscience, Inc. (0), greater than Motus GI Holdings, Inc. (-2505361.00), greater than IRIDEX Corporation (26.07M), greater than Sight Sciences, Inc. (97.91M), greater than STRATA Skin Sciences, Inc. (21.80M), greater than Aziyo Biologics, Inc. (139.81M), greater than enVVeno Medical Corporation (38.47M),

Build a custom stock screener for Myomo, Inc. (MYO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Myomo, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Myomo, Inc. (MYO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Myomo, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.